Parkside Financial Bank & Trust buys 95 shares of Xylem Inc. (NYSE:XYL)

Parkside Financial Bank & Trust raised its stake in Xylem Inc. (NYSE:XYL – Free Report) by 3.1% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 3,169 shares of the industrial products company’s stock after acquiring an additional 95 shares during the quarter. Parkside Financial Bank & Trust’s holdings in Xylem were worth $430,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Swedbank AB purchased a new position in Xylem in the first quarter valued at approximately $311,684,000. Norges Bank acquired a new stake in Xylem during the fourth quarter valued at $198,207,000. Artisan Partners Limited Partnership purchased a new stake in Xylem during the fourth quarter valued at $187,207,000. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main boosted its holdings in Xylem by 1,503.7% in the fourth quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 1,649,926 shares of the industrial products company’s stock valued at $188,685,000 after purchasing an additional 1,547,043 shares during the period. Finally, Kodai Capital Management LP purchased a new position in shares of Xylem in the 4th quarter valued at $133,945,000. Institutional investors and hedge funds own 87.96% of the company’s shares.

Xylem trading down 1.0%

XYL opened at $126.81 on Friday. Xylem Inc. has a 1 year low of $87.59 and a 1 year high of $146.08. The stock has a market cap of $30.80 billion, a PE ratio of 45.13, a PEG ratio of 2.27 and a beta of 1.04. The company has a current ratio of 1.85, a quick ratio of 1.33, and a debt-to-equity ratio of 0.19. The firm has a 50 day moving average price of $134.13 and a two hundred day moving average price of $133.70.

Xylem (NYSE:XYL – Get Your Free Report ) last issued its quarterly earnings data on Tuesday, July 30th. The industrial products company reported $1.09 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.04. The firm had revenue of $2.17 billion during the quarter, compared to analysts’ expectations of $2.14 billion. Xylem had a net margin of 9.11% and a return on equity of 9.48%. Xylem’s revenue rose 26.0% year over year. In the same quarter last year, the company posted EPS of $0.98. As a group, equities analysts anticipate that Xylem Inc. will post 4.26 earnings per share for the current fiscal year.

Xylem Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, September 26th. Investors of record on Thursday, August 29th will be issued a $0.36 dividend. This represents an annualized dividend of $1.44 and a yield of 1.14%. The ex-dividend date of this dividend is Thursday, August 29. Xylem’s dividend payout ratio is 51.25%.

Insider buying and selling

In other Xylem news, CAO Geri-Michelle Mcshane sold 2,278 shares of the company’s stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $138.63, for a total transaction of $315,799.14. Following the transaction, the chief accounting officer now directly owns 3,536 shares in the company, valued at approximately $490,195.68. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC’s website. Corporate insiders own 0.27% of the company’s shares.

Changes in Analyst Ratings

A number of analysts have recently analyzed the action. Royal Bank of Canada upped their target price on shares of Xylem from $160.00 to $163.00 and gave the company an “outperform” rating in a research note on Wednesday, July 31st. Stifel Nicolaus increased their price objective on Xylem from $170.00 to $172.00 and gave the company a “buy” rating in a research note on Wednesday, July 31st. TD Cowen restated a “hold” rating and set a $138.00 target price on shares of Xylem in a research report on Tuesday. Argus boosted their target price on Xylem from $146.00 to $165.00 and gave the company a “buy” rating in a research report on Wednesday, May 29th. Finally, UBS Group started coverage on Xylem in a report on Tuesday, August 13th. They set a “buy” rating and a $165.00 price objective for the company. Five investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. Xylem presently has a consensus rating of “Moderate Buy” and an average price target of $147.54, based on data from MarketBeat.

Check out our latest research report on Xylem

Xylem Company Profile

(Free report)

Xylem Inc, together with its subsidiaries, is engaged in the design, manufacture and service of engineering products and solutions worldwide. It operates through four segments: water infrastructure, applied water, measurement and control solutions, and integrated solutions and services. The Water Infrastructure segment offers products including pumps for water, stormwater and wastewater; controls and systems; filtration, disinfection and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco and Xylem Vue brands.

Read more

Want to see what other hedge funds hold XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trading for Xylem Inc. (NYSE:XYL – Free Report).

Get news and reviews for Xylem Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Xylem and related companies with MarketBeat.com ‘s FREE daily email newsletter.